Diane Gosselin, now President and CEO of CQDM, joined the organization in 2008 as Vice President, Research and Business Development where she was responsible for establishing all funding programs and managing the corporate development activities. She has twenty years of experience in research and corporate financing, namely at the Fonds de solidarité FTQ where she helped several companies implement their drug development strategy and was actively involved in the elaboration of a strategic initiative aimed at promoting innovation in the life sciences sector. She took part in several technological maturation matters, notably as a board member of the Bio-Innovation Fund (2005-2008). She also served as a board member of Cardianove and the Biotechnologies Oceanova (2005-2008). At PROCREA BioSciences, she led the research team that created and developed the first non-invasive diagnostic test for endometriosis. Mrs. Gosselin holds a Ph.D. in microbiology and immunology from Université de Montréal, as well as an Executive MBA from the Université du Québec à Montréal and Université Paris-Dauphine.